AVPR1B IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with AVPR1B IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with AVPR1B IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with AVPR1B IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with AVPR1B IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

A-kinase anchoring protein 17A

Gene

WD repeat domain 46

Gene

zinc finger protein 826, pseudogene

Gene

STAG3 cohesin complex component like 3 (pseudogene)

Gene

protein FAM169B

Gene

keratin 18 pseudogene 41

Gene

elongin A3 family member B, pseudogene

Gene

kelch like family member 2 pseudogene 1

Gene

MAPK regulated corepressor interacting protein 2 pseudogene 2

Gene

double homeobox 4 like 34 (pseudogene)

  • Gene

    A-kinase anchoring protein 17A


  • Gene

    WD repeat domain 46


  • Gene

    zinc finger protein 826, pseudogene


  • Gene

    STAG3 cohesin complex component like 3 (pseudogene)



  • Gene

    keratin 18 pseudogene 41


  • Gene

    elongin A3 family member B, pseudogene


  • Gene

    kelch like family member 2 pseudogene 1


  • Gene

    MAPK regulated corepressor interacting protein 2 pseudogene 2


  • Gene

    double homeobox 4 like 34 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.